- Company Overview for ONCODRUG LTD (13542017)
- Filing history for ONCODRUG LTD (13542017)
- People for ONCODRUG LTD (13542017)
- More for ONCODRUG LTD (13542017)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
09 Aug 2024 | CS01 | Confirmation statement made on 9 August 2024 with no updates | |
06 Aug 2024 | PSC01 | Notification of Richard Marais as a person with significant control on 31 October 2022 | |
06 Aug 2024 | PSC04 | Change of details for Professor Caroline Joy Springer as a person with significant control on 31 October 2022 | |
13 May 2024 | AA | Total exemption full accounts made up to 31 August 2023 | |
17 Oct 2023 | AP01 | Appointment of Mr Philip Masterson as a director on 17 October 2023 | |
14 Aug 2023 | CS01 | Confirmation statement made on 9 August 2023 with updates | |
14 Apr 2023 | AA | Accounts for a dormant company made up to 31 August 2022 | |
25 Nov 2022 | SH01 |
Statement of capital following an allotment of shares on 16 November 2022
|
|
23 Nov 2022 | RESOLUTIONS |
Resolutions
|
|
23 Nov 2022 | SH02 | Sub-division of shares on 16 November 2022 | |
23 Nov 2022 | RESOLUTIONS |
Resolutions
|
|
31 Oct 2022 | SH01 |
Statement of capital following an allotment of shares on 31 October 2022
|
|
30 Sep 2022 | AP01 | Appointment of Professor Richard Marais as a director on 30 September 2022 | |
09 Aug 2022 | CS01 | Confirmation statement made on 9 August 2022 with no updates | |
02 Aug 2021 | NEWINC |
Incorporation
Statement of capital on 2021-08-02
|